Purchases and Sales Made in Q4 2024 in Syndax Pharmaceuticals Inc (SNDX)
This table provides information about the institutional ownership of Syndax Pharmaceuticals Inc (SNDX) during Q4 2024. The information is specifically focused on institutions that hold shares of Syndax Pharmaceuticals Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-25.5K- 5.54% |
$319K - $556K
|
434K
$7.11M
|
|
|
Feb 13, 2025
Q4 2024
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-27.5K- 10.6% |
$344K - $600K
|
232K
$3.8M
|
|
|
Feb 11, 2025
Q4 2024
|
Sei Investments CO
Oaks, PA |
SELL
|
- |
-35.4K- 70.14% |
$443K - $772K
|
15.1K
$247K
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-41.1K- 24.39% |
$515K - $897K
|
128K
$2.09M
|
|
|
Feb 14, 2025
Q4 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-45.4K- 48.15% |
$568K - $989K
|
48.8K
$800K
|
|
|
Feb 12, 2025
Q4 2024
|
Axiom Investors LLC
Greenwich, CT |
SELL
|
- |
-62.4K- 53.98% |
$781K - $1.36M
|
53.2K
$872K
|
|
|
Feb 14, 2025
Q4 2024
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-63.4K- 26.03% |
$793K - $1.38M
|
180K
$2.95M
|
|
|
Feb 12, 2025
Q4 2024
|
Bit Capital Gmb H
Berlin, 2M |
SELL
|
- |
-88KClosed |
$1.1M - $1.92M
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-89K- 20.94% |
$1.11M - $1.94M
|
336K
$5.5M
|
|
|
Feb 13, 2025
Q4 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-93.9K- 25.95% |
$1.18M - $2.05M
|
268K
$4.39M
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-121K- 90.45% |
$1.51M - $2.63M
|
12.7K
$209K
|
|
|
Feb 14, 2025
Q4 2024
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-128K- 16.31% |
$1.61M - $2.8M
|
659K
$10.8M
|
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-133K- 19.93% |
$1.67M - $2.91M
|
536K
$8.78M
|
|
|
Feb 14, 2025
Q4 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-167K- 88.98% |
$2.09M - $3.64M
|
20.7K
$338K
|
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-168K- 47.75% |
$2.11M - $3.67M
|
184K
$3.02M
|
|
|
Feb 12, 2025
Q4 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-170K- 53.34% |
$2.13M - $3.7M
|
149K
$2.43M
|
|
|
Feb 14, 2025
Q4 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-196K- 23.94% |
$2.45M - $4.27M
|
622K
$10.2M
|
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-217K- 24.44% |
$2.71M - $4.73M
|
670K
$11M
|
|
|
Feb 14, 2025
Q4 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-217K- 51.2% |
$2.72M - $4.73M
|
207K
$3.39M
|
|
|
Feb 14, 2025
Q4 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-298K- 81.05% |
$3.73M - $6.49M
|
69.6K
$1.14M
|
|
|
Feb 06, 2025
Q4 2024
|
Candriam S.C.A.
|
SELL
|
- |
-451K- 45.21% |
$5.65M - $9.85M
|
547K
$8.96M
|
|
|
Feb 14, 2025
Q4 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-454K- 93.42% |
$5.69M - $9.91M
|
32K
$524K
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-512K- 67.58% |
$6.41M - $11.2M
|
246K
$4.02M
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-533K- 47.6% |
$6.68M - $11.6M
|
587K
$9.61M
|
|
|
Feb 14, 2025
Q4 2024
|
First Turn Management, LLC
Del Mar, CA |
SELL
|
- |
-746K- 62.8% |
$9.33M - $16.3M
|
442K
$7.23M
|
|
|
Feb 12, 2025
Q4 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-752K- 15.07% |
$9.41M - $16.4M
|
4.23M
$69.4M
|
|
|
Feb 14, 2025
Q4 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-863K- 31.05% |
$10.8M - $18.8M
|
1.92M
$31.4M
|
|
|
Feb 14, 2025
Q4 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-955K- 38.9% |
$12M - $20.8M
|
1.5M
$24.6M
|
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-977K- 98.72% |
$12.2M - $21.3M
|
12.6K
$207K
|
|
|
Feb 14, 2025
Q4 2024
|
Avoro Capital Advisors LLC
New York, NY |
SELL
|
- |
-1.61M- 41.49% |
$20.2M - $35.2M
|
2.28M
$37.3M
|
|
|
Feb 14, 2025
Q4 2024
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-3.76M- 91.64% |
$47.1M - $82M
|
343K
$5.62M
|